Abdominal ImagingThe Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic CancerNunna, Pratyusha MD*; Sheikhbahaei, Sara MD, MPH*; Ahn, Sejin MD*; Young, Brenda*; Subramaniam, Rathan M. MD, PhD, MPH*†‡Author Information From the *Russell H Morgan Department of Radiology and Radiological Sciences, †Department of Oncology, Johns Hopkins School of Medicine, and ‡Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Received for publication July 16, 2015; accepted July 20, 2015. Correspondence to: Rathan M. Subramaniam, MD, PhD, MPH, Russell H Morgan Department of Radiology and Radiology Science, Johns Hopkins Medical Institutions, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287 (e-mail: firstname.lastname@example.org). The authors declare no conflict of interest. Journal of Computer Assisted Tomography: January/February 2016 - Volume 40 - Issue 1 - p 142-151 doi: 10.1097/RCT.0000000000000323 Buy Metrics Abstract The role of positron emission tomography (PET) and PET/computed tomography (CT) in the management of pancreatic cancer patients has not been clearly established. Although value of PET/CT in the staging of pancreatic cancer is still being debated, several studies pointed to its superior role in determining therapy response, recurrence detection, and survival prediction in comparison to conventional imaging including contrast-enhanced CT. This article reviews the current literature on usefulness of PET/CT in the management of pancreatic cancer patients. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.